Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06772831 · ClinicalTrials.gov registry record · NA

Cognitive Reappraisal Training for Borderline Personality (BPD)

A NA study of Borderline Personality Disorder, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT06772831 is a NA study of Borderline Personality Disorder that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 130 participants, above the 99-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (31% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06772831, a NA study of Borderline Personality Disorder, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

Previous work by the group convinced the researchers to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed clinical intervention for BPD patients, training in reappraisal-by-distancing, in terms of its ability to influence hypothesized neural and behavioral targets and, once that is established, to demonstrate its ability improve clinically relevant outcome measures.

Conditions Studied

Borderline Personality Disorder

Interventions

  • BEHAVIORAL Cognitive Reappraisal by Distancing
  • BEHAVIORAL Downregulate condition

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2024-11-15
Est. Completion 2027-07-31
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06772831

The ClinicalTrials.gov registry entry for NCT06772831 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 99-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (31% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Borderline Personality Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Reappraisal by Distancing is the first listed.

NCT06772831 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06772831 about?

NCT06772831 is a clinical study titled "Cognitive Reappraisal Training for Borderline Personality (BPD)". Previous work by the group convinced the researchers to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in concert with evidence-based treatments of BPD. The present proposal aims to refine and test a proposed c...

What is the current status of trial NCT06772831?

This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2024-11-15. Estimated completion is 2027-07-31.

What conditions does trial NCT06772831 study?

This clinical trial studies the following conditions: Borderline Personality Disorder.

What interventions are being tested in trial NCT06772831?

The interventions under investigation include: Cognitive Reappraisal by Distancing (BEHAVIORAL), Downregulate condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT06772831?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06772831 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Borderline Personality Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Borderline Personality Disorder

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.